Please wait while the formulary information is being retrieved.
REALHEAL-I (lidocaine/prilocaine)
- administration of local anesthetic drug
- Valladerm-90 Topical Kit
- Skyaderm-lp Topical Kit
- Relador Pak Topical Kit
- Relador Pak Plus Topical Kit
- Realheal-i Topical Kit
- Prilovix Ultralite Plus Topical Kit
- Prilovix Topical Kit
- Prilovix Plus Topical Kit
- Prilovix Lite Plus Topical Kit
- Priloheal Plus 30 Topical Kit
- Livixil Pak Topical Kit
- Lidotor Topical Kit
- Lidocaine-prilocaine Topical Kit
- Lido-prilo Caine Pack Topical Kit
- Dermacinrx Prizopak Topical Kit
- Aprizio Pak Topical Kit
- Anodyne Lpt Topical Kit
- Agoneaze Topical Kit
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
Prilovix 2.5 %-2.5 % topical kit
- Dosage information is not available
Plus 2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Large open wound
- Methemoglobinemia
Contraindicated
- Cardiac arrhythmia
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Heart block
- Hemolytic anemia from pyruvate kinase and g6PD deficienc
- Sepsis
- Shock
Severe
Moderate
- Disease of liver
- Respiratory depression
- Seizure disorder
REALHEAL-I (lidocaine/prilocaine)
- administration of local anesthetic drug
- None
- Localized edema
- Pallor
- Pruritus of skin
- Skin rash
- Treatment site sequelae
- Vasodilation of blood vessels
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Bradycardia
- CNS toxicity
- Drowsy
- Headache disorder
- Hypotension
- Methemoglobinemia
- Respiratory depression
- Seizure disorder
Less Severe
- None
Contraindicated
None
Severe Precaution
Lidocaine (Top)
Rare risk of methemoglobinemia in infants age < 6 months. Use dose based on age, body weight and physical condition.
Rare risk of methemoglobinemia in infants age < 6 months. Adhere closely to dosing guidelines age < 10 years.
- 1 Day – 179 Days
- Rare risk of methemoglobinemia in infants age < 6 months. Use dose based on age, body weight and physical condition.
Prilocaine
Rare risk of methemoglobinemia in infants age < 6 months. Use dose based on age, body weight and physical condition.
Rare risk of methemoglobinemia in infants age < 6 months. Adhere closely to dosing guidelines age < 10 years.
- 1 Day – 179 Days
- Rare risk of methemoglobinemia in infants age < 6 months. Adhere closely to dosing guidelines age < 10 years.
Management or Monitoring Precaution
Lidocaine (Top)
Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
Rare risk of methemoglobinemia. Adhere closely to dosing guidelines age < 10 years.
- 180 Days – 13 Years
- Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
- 180 Days – 10 Years
- Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
Prilocaine
Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
Rare risk of methemoglobinemia. Adhere closely to dosing guidelines age < 10 years.
- 180 Days – 13 Years
- Rare risk of methemoglobinemia. Adhere closely to dosing guidelines age < 10 years.
- 180 Days – 10 Years
- Rare risk of methemoglobinemia. Adhere closely to dosing guidelines age < 10 years.
Lidocaine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Prilocaine Hydrochloride
- Severity Level:
2
- Additional Notes: Insuff data available; weigh maternal benefit vs potential fetal risk
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Prilocaine
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
Lidocaine
Amount excreted reported to be low with low infant oral bioavailability
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Excreted | Not known; no or inclusive data | Amount excreted reported to be low with low infant oral bioavailability |
Contraindicated
None
Precaution Exists
Select Anesthetics
General-May be more sensitive to CNS and cardiac adverse reactions. Consider dose reduction due to reduced clearance in the elderly.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | Y | Y | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
Formulary Reference Tool